40 Hz Gamma Waves and Alzheimer's Disease

A Flickering Light in a Dark Room

In 2015, a neuroscientist at MIT named Li-Huei Tsai did something that, at first glance, sounds more like a college dorm experiment than serious Alzheimer's research. She put mice in front of a flickering light.

Not just any flickering light. A light that turned on and off exactly 40 times per second. And what happened next was so unexpected that her own lab spent months re-running the experiments because they couldn't quite believe the results.

The mice in this study were genetically engineered to develop Alzheimer's disease. Their brains were filling up with amyloid-beta plaques, the sticky protein clumps that are one of the hallmarks of the disease. These plaques were accumulating just as they do in human Alzheimer's patients, slowly strangling neurons and erasing memories.

After one hour of exposure to 40 Hz flickering light, the amyloid-beta levels in the visual cortex of these mice dropped by roughly 50%.

Fifty percent. In one hour. From a flickering light.

This is the story of 40 Hz gamma brainwaves and Alzheimer's disease. It's a story about a specific brain frequency, a stubborn group of researchers, and a surprisingly simple idea that might reshape how we think about neurodegeneration. But to understand why any of this matters, and why you should be cautiously excited rather than skeptical, you need to understand what gamma waves actually are and why the Alzheimer's brain has a very specific problem with them.

What Does Your Brain's Fastest Rhythm Actually Do?

Your brain is an electrical organ. Right now, as you read this sentence, roughly 86 billion neurons are generating tiny electrical signals, and when large groups of them fire in synchrony, those signals combine into oscillating waves that we can measure through the skull with EEG.

Neuroscientists categorize these oscillations by frequency. Delta waves pulse slowly at 0.5 to 4 times per second, dominating deep sleep. alpha brainwaves hum along at 8 to 13 Hz when you're relaxed with your eyes closed. beta brainwaves, at 13 to 30 Hz, show up during active thinking and problem-solving.

And then there's gamma. The fast one. Gamma waves oscillate at 30 to 100 Hz, with a particularly important peak right around 40 Hz.

Gamma waves are special. They require extraordinary coordination. To get a population of neurons firing together 40 times per second, your brain needs precise timing across its circuitry. The neurons involved need to fire, rest, and fire again in exact lockstep, with millisecond precision.

This kind of coordination turns out to be essential for some of the brain's most sophisticated functions. When you focus intensely on something, gamma activity surges. When you bind together information from different senses (connecting the sight of a face with the sound of a voice, for instance), gamma oscillations synchronize distant brain regions. When you encode a new memory, a burst of gamma activity helps stamp it into your neural circuits.

Here's the key insight: gamma oscillations aren't just a byproduct of healthy brain function. They appear to be a mechanism that keeps the brain healthy.

And in Alzheimer's disease, this mechanism breaks down.

Why Does the Alzheimer's Brain Have a Gamma Problem?

Alzheimer's disease is defined by two pathological proteins: amyloid-beta plaques that accumulate between neurons, and tau tangles that form inside neurons. Together, they trigger a cascade of neuroinflammation, synaptic loss, and cell death that progressively destroys cognitive function.

For decades, the pharmaceutical industry poured billions into drugs that target amyloid plaques directly. The theory was straightforward: remove the plaques, stop the disease. But drug after drug failed in clinical trials. Some successfully reduced amyloid levels without improving cognition. Others showed modest slowing of decline but with concerning side effects. The "amyloid hypothesis," while still central to Alzheimer's research, clearly wasn't telling the whole story.

Meanwhile, a different thread of research was quietly accumulating. Studies using EEG and magnetoencephalography (MEG) were consistently finding that Alzheimer's patients showed reduced gamma oscillations compared to healthy controls. This wasn't subtle. The gamma deficit appeared early, sometimes before clinical symptoms were obvious, and it worsened as the disease progressed.

A 2016 study in Cell documented this precisely: people with early Alzheimer's showed significantly less 40 Hz gamma power during cognitive tasks. Their brains were struggling to produce the coordinated, high-frequency neural activity that healthy cognition depends on.

But was the gamma deficit a cause of Alzheimer's, or just a consequence? Were the dying neurons simply unable to maintain gamma rhythms, or was the loss of gamma itself contributing to the disease?

Tsai's lab set out to answer that question. And the answer changed everything.

The Experiment That Turned Heads

Li-Huei Tsai and her colleague Ed Boyden, both at MIT's Picower Institute for Learning and Memory, came to this problem from the world of optogenetics, a technique that uses light to control genetically modified neurons with millisecond precision.

Their first experiment, published in Nature in 2016, used optogenetics to directly drive neurons in the hippocampus of Alzheimer's model mice at exactly 40 Hz. The results were striking. The 40 Hz stimulation didn't just make the neurons fire in rhythm. It activated microglia, the brain's resident immune cells, and these activated microglia began engulfing and clearing amyloid-beta plaques.

Think about that for a moment. The brain has its own cleanup crew, cells whose literal job is to remove toxic waste. And a specific rhythm of neural activity, 40 Hz, seemed to wake them up and put them to work.

But optogenetics requires genetic modification and implanted fiber optics. You can't use it on humans. So Tsai's lab asked the obvious next question: could you achieve the same effect non-invasively?

That's when the flickering light entered the picture.

The principle is called neural entrainment. When you expose the brain to a rhythmic external stimulus, like a flickering light or a pulsing sound, the brain's neurons tend to synchronize their firing to match that rhythm. Show someone a light flickering at 40 Hz, and the neurons in their visual cortex will start oscillating at 40 Hz. It's the same reason your foot starts tapping when you hear a beat.

The 2016 study showed that non-invasive 40 Hz flickering light reduced amyloid-beta in the visual cortex of Alzheimer's model mice by roughly 40-50% after just one hour. With repeated daily sessions, the effects spread. By 2019, Tsai's lab published results showing that combined 40 Hz light and sound stimulation (what they call GENUS, for Gamma Entrainment Using Sensory Stimuli) reduced amyloid plaques and tau tangles across multiple brain regions, not just the visual cortex. The combined stimulation also reduced brain inflammation, prevented neuronal loss, and preserved cognitive function in the mice.

The question everyone was asking: does any of this translate to humans?

From Mice to Humans: Where the Research Stands Now

Moving from mouse models to human clinical trials is where most promising Alzheimer's treatments go to die. The history of the field is littered with therapies that worked beautifully in mice and failed completely in people. So the neuroscience community greeted the GENUS approach with a mixture of excitement and hard-earned skepticism.

The first small human studies were cautious. A 2019 pilot study at MIT exposed 10 participants with early Alzheimer's to 40 Hz light and sound stimulation for one hour per day. After several weeks, the participants showed increased gamma power on EEG (confirming that entrainment was working) and improvements in functional connectivity between brain regions. A separate pilot study published in PLOS ONE found similar results, with participants showing improved scores on cognitive assessments after several weeks of daily sessions.

But pilot studies are small and lack control groups. The real test came with larger, controlled trials.

In 2023, Cognito Therapeutics (a company co-founded by Tsai and Boyden to commercialize the GENUS approach) reported results from a 76-participant randomized controlled trial. Participants with mild to moderate Alzheimer's used a device delivering 40 Hz light and sound stimulation for one hour daily over six months. The treatment group showed a 77% reduction in functional brain atrophy compared to the sham group, measured by MRI. They also showed a 76% reduction in atrophy of the hippocampus, the brain's memory center and one of the first regions Alzheimer's destroys.

These results are genuinely encouraging. But it's important to be precise about what they do and don't prove. The brain atrophy findings are impressive. Slowing the physical shrinkage of the brain in Alzheimer's patients is meaningful. But the cognitive improvements, the thing patients and families care about most, have been modest in trials so far. Some studies show trends toward improved cognition, but the effect sizes are small and not always statistically significant.

This doesn't mean the approach doesn't work. It might mean the trials need to be longer, the patients need to be caught earlier, or the stimulation parameters need optimization. But honest reporting demands we say: the jury is still out on whether 40 Hz gamma stimulation will meaningfully change the cognitive trajectory of Alzheimer's disease in humans.

Phase III clinical trials are ongoing. The next few years will be decisive.

The Neurosity Crown gives you real-time access to your own brainwave data across 8 EEG channels at 256Hz, with on-device processing and open SDKs.

See the Crown

Why 40 Hz? What's So Special About This Frequency?

This is the question that nags at every scientist who encounters this research. The brain produces gamma oscillations across a range of frequencies. Why does 40 Hz specifically seem to activate the brain's cleanup machinery?

The honest answer: we're not entirely sure. But there are compelling hypotheses.

One theory involves a type of brain cell called a parvalbumin-positive (PV) interneuron. These are inhibitory neurons, cells that tell other neurons to stop firing, and they play a critical role in generating gamma rhythms. PV interneurons are like the conductors of the neural orchestra. They enforce the precise timing that keeps large populations of neurons firing in lockstep.

In Alzheimer's disease, PV interneurons are among the first cells to become dysfunctional. As they fail, the brain loses its ability to generate coordinated gamma rhythms. And without gamma rhythms, the microglia that normally patrol the brain and clear debris appear to become sluggish and disorganized.

Here's the "I had no idea" moment: microglia, the brain's immune cells, appear to have receptors that respond to the electrical fields generated by gamma oscillations. The rhythmic waves of 40 Hz activity may literally be a signal that tells microglia to activate their cleanup functions. When gamma oscillations disappear, the microglia lose that signal. Waste accumulates. Plaques build up. And the plaques further damage the PV interneurons, which further reduces gamma activity, creating a vicious cycle.

The 40 Hz stimulation may break this cycle by doing from the outside what the brain can no longer do from within: providing the rhythmic signal that keeps the cleanup crew working.

• PV interneurons generate 40 Hz gamma rhythms but are damaged early in Alzheimer's
• Microglia (brain immune cells) respond to the electrical fields of gamma oscillations
• Loss of gamma rhythm may cause microglia to become inactive, allowing plaque buildup
• External 40 Hz stimulation may restore the signal that keeps microglia clearing waste
• This creates a potential intervention point that doesn't require drugs to cross the blood-brain barrier

There's also evidence that 40 Hz is optimal because it matches the natural resonance frequency of certain thalamocortical circuits, the loops connecting the thalamus (the brain's sensory relay station) with the cortex. These circuits oscillate naturally around 40 Hz during wakeful attention, and driving them at their preferred frequency may produce the strongest and most widespread entrainment effect.

Beyond the Flickering Light: Other Approaches to 40 Hz Gamma Stimulation

While the Tsai Lab's GENUS approach (light and sound stimulation) gets the most attention, researchers are exploring multiple ways to boost 40 Hz gamma activity in the brain.

Transcranial alternating current stimulation (tACS) applies weak electrical currents to the scalp at 40 Hz, directly driving cortical neurons to oscillate at that frequency. Several studies have shown that 40 Hz tACS can improve working memory in both healthy adults and people with early cognitive impairment. A 2022 study in Science Translational Medicine found that daily 40 Hz tACS over eight months improved memory and reduced brain atrophy in Alzheimer's patients.

40 Hz sound-only stimulation is being explored as a simpler alternative to combined light-and-sound approaches. Auditory clicks at 40 Hz entrain the auditory cortex and, through connected networks, influence gamma activity in broader brain regions including the hippocampus. This matters because some participants find the flickering light uncomfortable, and a sound-only approach would be more tolerable for daily use.

Meditation and focused attention naturally increase gamma power, though not necessarily at a locked 40 Hz. Experienced meditators, particularly long-term practitioners of Tibetan Buddhist compassion meditation, show dramatically higher gamma activity compared to novice meditators. A landmark study by neuroscientist Richard Davidson found that experienced meditators produced gamma oscillations with amplitudes up to 30 times stronger than those of the control group. While meditation doesn't provide the precise 40 Hz lock of external stimulation, it represents a natural pathway to enhanced gamma activity.

Neurofeedback offers yet another approach. By monitoring gamma band activity with EEG and providing real-time feedback, individuals can learn to voluntarily increase their own gamma power. This is slower than external stimulation but has the advantage of training the brain's intrinsic capacity to generate gamma rhythms rather than relying on external devices.

What This Means for Brain Health Right Now

Let's be clear about where the science stands. The 40 Hz gamma stimulation research is among the most exciting developments in Alzheimer's research in the past decade. But it is not yet an approved treatment. Clinical trials are ongoing. The mechanisms in humans are still being confirmed. And anyone selling a "40 Hz Alzheimer's cure" device is getting ahead of the evidence.

That said, the broader implications of this research extend well beyond Alzheimer's treatment.

The finding that gamma oscillations play an active role in brain maintenance, not just brain function, is a fundamental insight. It suggests that the health of your brain depends not just on what you eat, how much you exercise, and how well you sleep (though all of those matter enormously), but also on the quality and vigor of your brain's electrical activity.

This reframes the conversation about cognitive health. Your brain isn't just a static organ that degrades over time. It's a dynamic electrical system, and the patterns of activity in that system influence everything from waste clearance to inflammation to synaptic strength.

Measuring What Matters: Gamma Waves and Personal Brain Monitoring

Here's where the Alzheimer's gamma research connects to something you can actually act on today.

One of the most consistent findings across all the 40 Hz research is that gamma activity is measurable with EEG, and changes in gamma power show up clearly in the data. The researchers tracking these trials aren't using exotic imaging technology. They're using electroencephalography, the same fundamental technology that Hans Berger first used in 1929 to record human brainwaves.

What's changed is accessibility. Clinical EEG systems used to cost tens of thousands of dollars and required a technician to apply electrode gel across 64 or more scalp positions. Today, consumer-grade EEG devices can capture meaningful gamma band data with dry electrodes.

The Neurosity Crown, for instance, samples brain activity at 256 Hz across 8 channels positioned at CP3, C3, F5, PO3, PO4, F6, C4, and CP4. These positions cover frontal, central, and parietal-occipital regions, giving you visibility into the brain networks where gamma activity matters most. The device provides real-time power spectral density data, which means you can track gamma band power (30-100 Hz) as it changes during different mental states and activities.

Why does this matter in the context of the Alzheimer's research? Because gamma activity isn't just relevant to disease. It's a window into the overall coordination and health of your neural circuitry. Higher gamma power during cognitive tasks correlates with better attention, faster memory encoding, and more efficient information processing. Tracking your gamma activity over time gives you a biomarker for the quality of your brain's highest-frequency coordination.

For researchers and developers, the implications are even more interesting. The Crown's JavaScript and Python SDKs provide access to raw EEG data at 256 Hz, which is more than sufficient to analyze gamma band activity with standard signal processing techniques. You could build applications that track gamma power during specific cognitive tasks, measure how different activities (exercise, meditation, sleep quality) affect your gamma baseline, or even experiment with audio-based entrainment protocols while monitoring the brain's response in real-time.

This isn't about treating Alzheimer's with a consumer device. That would be irresponsible to suggest. But it is about something genuinely important: developing a personal, ongoing relationship with your brain's electrical health, informed by the same frequency bands that scientists are discovering play active roles in neural maintenance.

The Bigger Picture: A New Way of Thinking About the Brain

The 40 Hz gamma story is part of a larger shift in neuroscience. For most of the 20th century, we thought of the brain primarily through the lens of chemistry: neurotransmitters, receptors, drugs that modify synaptic signaling. The pharmaceutical approach to brain disease followed this chemical paradigm. If something's wrong, find a molecule that fixes it.

The gamma research suggests that the brain's electrical activity isn't just an epiphenomenon of chemical signaling. It's a functional layer of brain physiology in its own right. The rhythmic patterns of neural oscillations, the timing, frequency, and synchronization of electrical activity across brain regions, appear to play causal roles in processes as fundamental as immune function and waste clearance.

This is a genuinely new idea. Not "new" in the sense that nobody thought about brainwaves before. EEG has been around for nearly a century. But "new" in the sense that oscillations were long treated as readouts of brain activity, not as active participants in brain health.

If this view holds up, and the evidence is increasingly pointing that direction, it means that the electrical patterns in your brain are not just interesting to measure. They are something worth cultivating, monitoring, and understanding, the same way you'd monitor your heart rate, your blood pressure, or your sleep architecture.

We are, possibly, at the beginning of a new era in which brain health monitoring includes a genuine electrical dimension. Not just "are you focused?" or "are you relaxed?" but "are your neural circuits coordinating at the frequencies that keep your brain's maintenance systems running?"

That era isn't science fiction. The research is published in Nature, Cell, and Science Translational Medicine. The clinical trials are registered on ClinicalTrials.gov. And the tools to observe your own brain's gamma activity are sitting on a desk in Brooklyn, weighing 228 grams, ready to ship.

The question isn't whether your brain's electrical rhythms matter. The 40 Hz research has settled that. The question is what you're going to do with the ability to see them.